US Bancorp’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Sell
7,138
-862
-11% -$43.8K ﹤0.01% 1796
2026
Q1
$427K Sell
8,000
-20,714
-72% -$1.22M ﹤0.01% 1586
2025
Q4
$1.78M Sell
28,714
-678
-2% -$41.9K ﹤0.01% 926
2025
Q3
$1.77M Sell
29,392
-2,037
-6% -$125K ﹤0.01% 919
2025
Q2
$1.97M Sell
31,429
-2,671
-8% -$161K ﹤0.01% 862
2025
Q1
$2.05M Sell
34,100
-2,354
-6% -$146K ﹤0.01% 844
2024
Q4
$2.13M Sell
36,454
-2,024
-5% -$120K ﹤0.01% 846
2024
Q3
$2.28M Buy
38,478
+1,024
+3% +$58.5K ﹤0.01% 822
2024
Q2
$2.1M Sell
37,454
-3,390
-8% -$190K ﹤0.01% 829
2024
Q1
$2.39M Sell
40,844
-10,496
-20% -$593K ﹤0.01% 776
2023
Q4
$2.77M Sell
51,340
-5,599
-10% -$274K ﹤0.01% 731
2023
Q3
$2.76M Buy
56,939
+10,794
+23% +$574K ﹤0.01% 692
2023
Q2
$2.61M Buy
46,145
+3,734
+9% +$206K ﹤0.01% 716
2023
Q1
$2.29M Buy
42,411
+4,419
+12% +$235K ﹤0.01% 764
2022
Q4
$2M Buy
37,992
+6,418
+20% +$326K ﹤0.01% 821
2022
Q3
$1.49M Buy
31,574
+2,354
+8% +$122K ﹤0.01% 889
2022
Q2
$1.47M Sell
29,220
-7,756
-21% -$423K ﹤0.01% 937
2022
Q1
$2.25M Sell
36,976
-48,354
-57% -$2.88M ﹤0.01% 844
2021
Q4
$5.62M Sell
85,330
-3,221
-4% -$206K 0.01% 554
2021
Q3
$5.56M Sell
88,551
-10,449
-11% -$667K 0.01% 543
2021
Q2
$5.96M Buy
99,000
+10,776
+12% +$623K 0.01% 534
2021
Q1
$4.86M Buy
88,224
+14,724
+20% +$817K 0.01% 559
2020
Q4
$4.01M Buy
73,500
+9,774
+15% +$511K 0.01% 587
2020
Q3
$3.18M Buy
63,726
+7,944
+14% +$385K 0.01% 603
2020
Q2
$2.46M Buy
55,782
+26,736
+92% +$1.14M 0.01% 660
2020
Q1
$1.09M Buy
29,046
+5,106
+21% +$215K ﹤0.01% 870
2019
Q4
$1.05M Sell
23,940
-4,410
-16% -$185K ﹤0.01% 1038
2019
Q3
$1.17M Buy
28,350
+23,454
+479% +$960K ﹤0.01% 966
2019
Q2
$196K Buy
4,896
+2,028
+71% +$76.8K ﹤0.01% 1847
2019
Q1
$111K Sell
2,868
-4,110
-59% -$149K ﹤0.01% 2135
2018
Q4
$233K Sell
6,978
-900
-11% -$31.2K ﹤0.01% 1681
2018
Q3
$298K Buy
7,878
+4,176
+113% +$148K ﹤0.01% 1666
2018
Q2
$124K Buy
3,702
+534
+17% +$17.4K ﹤0.01% 2109
2018
Q1
$98K Sell
3,168
-150
-5% -$4.62K ﹤0.01% 2252
2017
Q4
$96K Buy
3,318
+2,718
+453% +$78.4K ﹤0.01% 2281
2017
Q3
$17K Sell
600
-924
-61% -$25.6K ﹤0.01% 2954
2017
Q2
$43K Buy
1,524
+1,356
+807% +$35.9K ﹤0.01% 2609
2017
Q1
$4K Sell
168
-12,132
-99% -$294K ﹤0.01% 3252
2016
Q4
$273K Sell
12,300
-174
-1% -$3.95K ﹤0.01% 1658
2016
Q3
$302K Sell
12,474
-66
-0.5% -$1.57K ﹤0.01% 1563
2016
Q2
$282K Buy
12,540
+240
+2% +$5.2K ﹤0.01% 1558
2016
Q1
$251K Sell
12,300
-102
-0.8% -$1.98K ﹤0.01% 1599
2015
Q4
$253K Buy
12,402
+102
+0.8% +$2.04K ﹤0.01% 1594
2015
Q3
$228K Hold
12,300
﹤0.01% 1666
2015
Q2
$246K Hold
12,300
﹤0.01% 1678
2015
Q1
$246K Hold
12,300
﹤0.01% 1704
2014
Q4
$231K Hold
12,300
﹤0.01% 1701
2014
Q3
$204K Hold
12,300
﹤0.01% 1750
2014
Q2
$210K Hold
12,300
﹤0.01% 1779
2014
Q1
$203K Hold
12,300
﹤0.01% 1772
2013
Q4
$190K Hold
12,300
﹤0.01% 1758
2013
Q3
$174K Hold
12,300
﹤0.01% 1756
2013
Q2
$161K Buy
+12,300
New +$159K ﹤0.01% 1756

Other funds holding IHI

US Bancorp's IHI Position: Q2 2026 in Review

US Bancorp reduced its iShares US Medical Devices ETF (IHI) stake by 11% in Q2 2026, selling an estimated $43.8K and leaving 7,138 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

US Bancorp first reported a position in IHI in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.96M in Q2 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • US Bancorp held 7,138 shares of iShares US Medical Devices ETF worth $353K as of Q2 2026.
  • US Bancorp sold 862 iShares US Medical Devices ETF shares in Q2 2026, an estimated $43.8K.
  • iShares US Medical Devices ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1796 holding.
  • US Bancorp first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's iShares US Medical Devices ETF position peaked at $5.96M in Q2 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.